drugset / Trial / NCT02230696

Comparative Safety and Efficacy of Two Steroid Treatments in the Relief of the Symptoms of Seasonal Allergic Rhinitis

NCT02230696

Phase 3 Completed 951 enrolled Padagis LLC
RandomizedParallel-groupTriple-blindTreatment

Summary

To compare safety and efficacy of Perrigo's steroid drug product compared with an FDA approved steroid drug product in the treatment of subjects with seasonal allergic rhinitis.

Timeline

Start
2014-08
Primary completion
2015-02
Completion
2015-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Azelastine Small molecule 137 ug Intranasal
Comparator Fluticasone propionate Other / unclassified 50 ug Intranasal